Assisted Reproductive Technology Market

Assisted Reproductive Technology Market (Technology: In Vitro Fertilization, Artificial Insemination, Surrogacy, and Others; and Procedure: Frozen Donor, Frozen Non-donor, Fresh Donor, Fresh Non-donor, and Embryo Banking) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Assisted Reproductive Technology Market Outlook 2031

  • The global industry was valued at US$ 25.9 Bn in 2022
  • It is estimated to grow at a CAGR of 9.4% from 2023 to 2031 and reach US$ 58.6 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of infertility is fueling the global assisted reproductive technology market expansion. A delay in maternal age coupled with chronic stress and unhealthy coping habits leads to an increase in cases of couples struggling to get pregnant. IVF and egg or embryo banks are popular assisted reproductive services augmenting market demand.

Prominent players operating in the global assisted reproductive technology industry are adopting artificial intelligence and investing heavily in innovative technologies that make fertility care more affordable and accessible. Governments in various countries are prompting healthcare insurers to integrate infertility treatment procedures into their plans.

Assisted Reproductive Technology Market

Market Introduction

Assisted Reproductive Technology (ART)is a medical procedure that assists in fertility issues or an inability to conceive children. ART treatments involve the manipulation of eggs, sperm, or embryos to enhance the chances of conception and the likelihood of a successful and safe pregnancy. The procedure is highly invasive, expensive, and time-consuming. Male infertility treatment options include surgery, hormone therapy, artificial insemination, and intracytoplasmic sperm injection.

In vitro fertilization or IVF is the most common ART procedure and involves fertilizing an egg with a sperm outside the body in a laboratory environment and then transferring the formed embryo to the uterus. The success of ART depends on several factors such as age, type of procedure, and extent or cause of infertility. R&D in ART and surge in cases of infertility are driving the market statistics.

Rise in Prevalence of Infertility Boosting Assisted Reproductive Technology Market Progress

Delay in maternal age, several environmental reasons, and an unhealthy lifestyle are key factors leading to the rise in the prevalence of infertility worldwide. Chronic stress, decreased attention to personal hygiene, and long working hours can affect sperm production and testosterone levels in men and affect ovulation cycles in women. As per the World Health Organization (WHO), an estimated 1 in 6 reproductive adults globally experience infertility in their lifetime.

According to a report by Inito, a Bengaluru-based medical technology company, over 27.5 million couples in India are struggling to conceive a child. This accounts for about 10-15% of total married couples in India. Medical research also shows that over 90% of infertility cases can be treated with drugs, surgery, and reproductive technologies such as IVF and artificial insemination. Surge in awareness about these treatment procedures and drugs is boosting the assisted reproductive technology market development.

R&D in Fertility Treatment Propelling Market Size

Advancements in fertility treatments range from drug options and surgeries to complex technological alternatives such as egg or embryo storage and artificial insemination. According to a report published in the National Center for Biotechnology Information, IVF success rates have stayed stagnant for years at 30% and researchers believe utilization of Artificial Intelligence (AI) can improve these numbers.

Adoption of AI in clinics can assist the practitioner in assessing embryo and gamete health with more accuracy and objectivity based on image classification. AI can also aid doctors to create a personalized treatment plan for couples. AI-enabled image-processing systems can help select embryos with the best implantation potential. Hence, integration of AI in fertility treatments is expected to spur the assisted reproductive technology market growth in the near future.

Pre-implantation genetic screening is a sophisticated system used to screen embryos for specific genetic conditions. It increases the probability of a successful and safe pregnancy. Innovation in cryopreservation of eggs, sperms, and embryos offers couples and individuals flexibility over their bodies and reproductive options.

Regional Outlook

According to a recent assisted reproductive technology market analysis, North America had largest share in 2022. Presence of a well-developed healthcare sector, rise in awareness about reproductive assistance, and R&D of reproductive medicines and solutions are augmenting the market dynamics of the region. As per the U.S Census Bureau, over the past three decades, women’s fertility in the age group 20 to 23 has decreased by 43.0% while first-time motherhood has risen by 67.0% in the age group of 35 to 39 years.

According to the latest assisted reproductive technology market forecast, the industry in Asia Pacific is expected to grow at a steady pace from 2023 to 2031. Surge in prevalence of infertility and changes in lifestyle among the young population are driving the market landscape in the region.

As per a national survey conducted in Japan in 2021, over 10% of all couples in the country suffer from infertility. The survey also pointed out that IVF has grown in popularity in Japan and the government plans to integrate the process and other fertility treatments into the national insurance policy.

Analysis of Key Players

According to recent assisted reproductive technology market trends, prominent manufacturers are investing heavily in the development of infertility intervention technologies. They are developing advanced fertility treatments for assisted conception and affordable egg donation processes for consumers. These activities are likely to increase their assisted reproductive technology industry share during the forecast period.

Merck KGaA, CooperSurgical, Inc., FUJIFILM Irvine Scientific., Vitrolife AB, Hamilton Thorne, Inc., Nikon Corporation, Nidacon International AB, Laboratoire CCD, and Esco Micro Pte. Ltd. are key firms operating in this market.

These companies have been profiled in the assisted reproductive technology market report based on various parameters such as company overview, business strategies, product portfolio, financial overview, and business segments.

Key Developments in Assisted Reproductive Technology Market

  • In December 2023, TMRW Life Sciences, a fertility technology company, announced its expansion in the U.K. fertility market. A fertility center in Liverpool, England, became the first non-U.S. clinic to adopt TMRW’s automated platform for frozen egg and embryo storage.
  • In December 2023, Freya BioSciences secured funding of US$ 38.0 Mn for the development of women’s reproductive immunotherapies. The company plans to use the funds to develop its microbiome sequencing and immune biomarker data platform.

Assisted Reproductive Technology Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 25.9 Bn
Market Forecast Value in 2031 US$ 58.6 Bn
Growth Rate (CAGR) 9.4%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players – Competition Dashboard and Revenue Share Analysis, 2022
  • Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Regions Covered
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia and CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC
  • South Africa
Market Segmentation
  • Technology
    • In Vitro Fertilization
      • Intra-cytoplasmic Sperm Injection (ICSI)
      • Preimplantation Genetic Diagnosis (PGD)
    • Artificial Insemination
      • Intrauterine Insemination (IUI)
      • Intracervical Insemination (ICI)
      • Others
    • Surrogacy
    • Others
  • Procedure
    • Frozen Donor
    • Frozen Non-donor
    • Fresh Donor
    • Fresh Non-donor
    • Embryo Banking
  • End-user
    • Fertility Clinics
    • Hospitals
    • Others
  • End User
    • Fertility Clinics
    • Hospitals
    • Others
Companies Profiled
  • Merck KGaA
  • CooperSurgical, Inc.
  • FUJIFILM Irvine Scientific.
  • Vitrolife AB
  • Hamilton Thorne, Inc.
  • Nikon Corporation
  • Nidacon International AB
  • Laboratoire CCD
  • Esco Micro Pte. Ltd.
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the global assisted reproductive technology market in 2022?

It was valued at US$ 25.9 Bn in 2022

How is the assisted reproductive technology business expected to grow by 2031?

It is projected to grow at a CAGR of 9.4% from 2023 to 2031

What are the key factors driving the demand for assisted reproductive technology?

Rise in prevalence of infertility and R&D in fertility treatment

Which assisted reproductive technology segment held the largest share in 2022?

The in vitro fertilization technology segment held the largest share in 2022

Which was the major region in the assisted reproductive technology landscape in 2022?

North America was the leading region in 2022

Who are the key assisted reproductive technology manufacturers?

Merck KGaA, CooperSurgical, Inc., FUJIFILM Irvine Scientific., Vitrolife AB, Hamilton Thorne, Inc., Nikon Corporation, Nidacon International AB, Laboratoire CCD, and Esco Micro Pte. Ltd.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Assisted Reproductive Technology Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Technology Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Assisted Reproductive Technology Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Technology/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Assisted Reproductive Technology Market Analysis and Forecast, by Technology

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Technology, 2017–2031

            6.3.1. In Vitro Fertilization

                6.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)

                6.3.1.2. Preimplantation Genetic Diagnosis (PGD)

            6.3.2. Artificial Insemination

                6.3.2.1. Intrauterine Insemination (IUI)

                6.3.2.2. Intracervical Insemination (ICI)

                6.3.2.3. Others

            6.3.3. Surrogacy

            6.3.4. Others

        6.4. Market Attractiveness Analysis, by Technology

    7. Global Assisted Reproductive Technology Market Analysis and Forecast, by Procedure

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Procedure, 2017–2031

            7.3.1. Frozen Donor

            7.3.2. Frozen Non-donor

            7.3.3. Fresh Donor

            7.3.4. Fresh Non-donor

            7.3.5. Embryo Banking

        7.4. Market Attractiveness Analysis, by Procedure

    8. Global Assisted Reproductive Technology Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Fertility Clinics

            8.3.2. Hospitals

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Assisted Reproductive Technology Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Assisted Reproductive Technology Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Technology, 2017–2031

            10.3.1. In Vitro Fertilization

                10.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)

                10.3.1.2. Preimplantation Genetic Diagnosis (PGD)

            10.3.2. Artificial Insemination

                10.3.2.1. Intrauterine Insemination (IUI)

                10.3.2.2. Intracervical Insemination (ICI)

                10.3.2.3. Others

            10.3.3. Surrogacy

            10.3.4. Others

        10.4. Market Value Forecast, by Procedure, 2017–2031

            10.4.1. Frozen Donor

            10.4.2. Frozen Non-donor

            10.4.3. Fresh Donor

            10.4.4. Fresh Non-donor

            10.4.5. Embryo Banking

        10.5. Market Value Forecast, by End-user, 2017–2031

            10.5.1. Fertility Clinics

            10.5.2. Hospitals

            10.5.3. Others

        10.6. Market Value Forecast, by Country, 2017–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Technology

            10.7.2. By Procedure

            10.7.3. By End-user

            10.7.4. By Country

    11. Europe Assisted Reproductive Technology Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Technology, 2017–2031

            11.3.1. In Vitro Fertilization

                11.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)

                11.3.1.2. Preimplantation Genetic Diagnosis (PGD)

            11.3.2. Artificial Insemination

                11.3.2.1. Intrauterine Insemination (IUI)

                11.3.2.2. Intracervical Insemination (ICI)

                11.3.2.3. Others

            11.3.3. Surrogacy

            11.3.4. Others

        11.4. Market Value Forecast, by Procedure, 2017–2031

            11.4.1. Frozen Donor

            11.4.2. Frozen Non-donor

            11.4.3. Fresh Donor

            11.4.4. Fresh Non-donor

            11.4.5. Embryo Banking

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Fertility Clinics

            11.5.2. Hospitals

            11.5.3. Others

        11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Technology

            11.7.2. By Procedure

            11.7.3. By End-user

            11.7.4. By Country/Sub-region

    12. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Technology, 2017–2031

            12.3.1. In Vitro Fertilization

                12.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)

                12.3.1.2. Preimplantation Genetic Diagnosis (PGD)

            12.3.2. Artificial Insemination

                12.3.2.1. Intrauterine Insemination (IUI)

                12.3.2.2. Intracervical Insemination (ICI)

                12.3.2.3. Others

            12.3.3. Surrogacy

            12.3.4. Others

        12.4. Market Value Forecast, by Procedure, 2017–2031

            12.4.1. Frozen Donor

            12.4.2. Frozen Non-donor

            12.4.3. Fresh Donor

            12.4.4. Fresh Non-donor

            12.4.5. Embryo Banking

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Fertility Clinics

            12.5.2. Hospitals

            12.5.3. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Technology

            12.7.2. By Procedure

            12.7.3. By End-user

            12.7.4. By Country/Sub-region

    13. Latin America Assisted Reproductive Technology Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Technology, 2017–2031

            13.3.1. In Vitro Fertilization

                13.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)

                13.3.1.2. Preimplantation Genetic Diagnosis (PGD)

            13.3.2. Artificial Insemination

                13.3.2.1. Intrauterine Insemination (IUI)

                13.3.2.2. Intracervical Insemination (ICI)

                13.3.2.3. Others

            13.3.3. Surrogacy

            13.3.4. Others

        13.4. Market Value Forecast, by Procedure, 2017–2031

            13.4.1. Frozen Donor

            13.4.2. Frozen Non-donor

            13.4.3. Fresh Donor

            13.4.4. Fresh Non-donor

            13.4.5. Embryo Banking

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Fertility Clinics

            13.5.2. Hospitals

            13.5.3. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Technology

            13.7.2. By Procedure

            13.7.3. By End-user

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Assisted Reproductive Technology Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Technology, 2017–2031

            14.3.1. In Vitro Fertilization

                14.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)

                14.3.1.2. Preimplantation Genetic Diagnosis (PGD)

            14.3.2. Artificial Insemination

                14.3.2.1. Intrauterine Insemination (IUI)

                14.3.2.2. Intracervical Insemination (ICI)

                14.3.2.3. Others

            14.3.3. Surrogacy

            14.3.4. Others

        14.4. Market Value Forecast, by Procedure, 2017–2031

            14.4.1. Frozen Donor

            14.4.2. Frozen Non-donor

            14.4.3. Fresh Donor

            14.4.4. Fresh Non-donor

            14.4.5. Embryo Banking

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Fertility Clinics

            14.5.2. Hospitals

            14.5.3. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Technology

            14.7.2. By Procedure

            14.7.3. By End-user

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Merck KGaA

                15.3.1.1. Company Overview

                15.3.1.2. Technology Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. CooperSurgical, Inc.

                15.3.2.1. Company Overview

                15.3.2.2. Technology Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. FUJIFILM Irvine Scientific

                15.3.3.1. Company Overview

                15.3.3.2. Technology Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Vitrolife AB

                15.3.4.1. Company Overview

                15.3.4.2. Technology Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. Hamilton Thorne, Inc.

                15.3.5.1. Company Overview

                15.3.5.2. Technology Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. Nikon Corporation

                15.3.6.1. Company Overview

                15.3.6.2. Technology Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. Nidacon International AB

                15.3.7.1. Company Overview

                15.3.7.2. Technology Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. Laboratoire CCD

                15.3.8.1. Company Overview

                15.3.8.2. Technology Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

            15.3.9. Esco Micro Pte. Ltd.

                15.3.9.1. Company Overview

                15.3.9.2. Technology Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Financial Overview

                15.3.9.5. Strategic Overview

    List of Tables

    Table 01: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 02: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

    Table 03: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 07: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

    Table 08: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 11: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

    Table 12: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 15: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

    Table 16: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 19: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

    Table 20: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 23: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

    Table 24: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Assisted Reproductive Technology Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031

    Figure 02: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Technology, 2022

    Figure 03: Global Assisted Reproductive Technology Market Value Share, by Technology, 2022

    Figure 04: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Procedure, 2022

    Figure 05: Global Assisted Reproductive Technology Market Value Share, by Procedure, 2022

    Figure 06: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by End-user, 2022

    Figure 07: Global Assisted Reproductive Technology Market Value Share, by End-user, 2022

    Figure 08: Global Assisted Reproductive Technology Market Value Share, by Region, 2022

    Figure 09: Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, 2023–2031

    Figure 10: Global Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 11: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 12: Global Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 13: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031

    Figure 14: Global Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 15: Global Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 16: Global Assisted Reproductive Technology Market Value Share Analysis, by Region, 2022 and 2031

    Figure 17: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Region, 2022-2031

    Figure 18: North America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 19: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Assisted Reproductive Technology Market Value Share Analysis, by Country, 2022 and 2031

    Figure 21: North America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 22: North America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 23: North America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 24: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 25: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

    Figure 26: North America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 27: Europe Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 28: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 30: Europe Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 31: Europe Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 32: Europe Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 33: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 34: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

    Figure 35: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 36: Asia Pacific Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 37: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 39: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 40: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 41: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 42: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 43: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

    Figure 44: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 45: Latin America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 46: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 48: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 49: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 50: Latin America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 51: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 52: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

    Figure 53: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 54: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 55: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 57: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 58: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 59: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 60: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 61: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

    Figure 62: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved